xanomeline 50 MG / trospium chloride 20 MG Oral Capsule
- RxCUI
- 2694843
- RxNorm name
- xanomeline 50 MG / trospium chloride 20 MG Oral Capsule
- Display name
- xanomeline 50 MG / trospium chloride 20 MG Oral Capsule
- Full name
- xanomeline 50 MG / trospium chloride 20 MG Oral Capsule
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cobenfy | XANOMELINE AND TROSPIUM CHLORIDE | E.R. Squibb & Sons, L.L.C. | 8f0e73bf-6025-44f6-ab64-0983322de0df | 2026-01-16 | Warnings, Adverse reactions | 2694843 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8f0e73bf-6025-44f6-ab64-0983322de0df | xanomeline 50 MG / trospium chloride 20 MG Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024 | 20260116 |
| 8f0e73bf-6025-44f6-ab64-0983322de0df | trospium chloride 20 MG / xanomeline 50 MG Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024 | 20260116 |
| 8f0e73bf-6025-44f6-ab64-0983322de0df | xanomeline 50 MG (equivalent to xanomeline tartrate 76.7 MG) / trospium chloride 20 MG (trospium 18.3 MG) Oral Capsule | SY | 4 | These highlights do not include all the information needed to use COBENFY safely and effectively. See full prescribing information for COBENFY. COBENFY™ (xanomeline and trospium chloride) capsules, for oral use Initial U.S. Approval: 2024 | 20260116 |